We use cookies for a better user experience. Read our Privacy Policy

I Agree

Menopausal Hot Flashes Treatment Market

Menopausal Hot Flashes Treatment Market (Treatment Type: Hormonal Treatment [Estrogen, Progesterone, and Estrogen–Progesterone Combination], Non-hormonal Treatment [Antidepressant, Gabapentin, Pregabalin, and Clonidine], and Alternative Treatment [Black Cohosh, Vitamin E, Herbal Medicines, and Others]; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Treatment Options Targeting Brain’s Thermostat Lead to Innovations in Non-hormonal Drugs

High prevalence of fluctuating estrogen levels and depleting musculoskeletal health among women are some of the key drivers contributing to the robust growth of the menopausal hot flashes treatment market. Hence, healthcare companies are increasing their clinical trials in non-hormonal products to meet various cases. Recently, in January 2020, the U.K.-based clinical-stage biotech company KaNDy Therapeutics, announced positive data of their Phase 2b “SWITCH-1” clinical trial of their novel lead non-hormonal drug candidate, NT-814, for the treatment of menopause. Though the hormonal treatment type segment is expected to lead the menopausal hot flashes treatment market, non-hormonal treatment type segment is anticipated for exponential growth during the forecast period.

Companies in the market for menopausal hot flashes are increasing R&D in treatment options that target the brain’s thermostat to reduce incidence of hot flashes in women. Such innovations are creating value-grab opportunities for companies in the market menopausal hot flashes treatment market, whilst improving the quality of life of postmenopausal women.

To know the scope of our report Get a Sample on Menopausal Hot Flashes Treatment Market?

Femtech to Explore Untapped Potential in Women’s Midlife Health Issues

The menopausal hot flashes treatment market is expected to grow at a CAGR of 6% during the forecast period. Most women from Generation X are now in their 40s and are technologically proficient. Likewise, online drug sales is anticipated to flourish in the market for menopausal hot flashes. However, there is a lack of interest from the femtech toward solving the issues of women’s midlife health issues.

The femtech sector has been more active toward solving the issues of menstrual health and pregnancy. However, there is a growing need for attention toward women’s midlife health issues such as menopausal hot flashes. Hence, companies are exploring untapped opportunities to address the stigma and associated silence pertaining to symptoms of menopause.

Companies in the menopausal hot flashes treatment market are targeting digitally literate women to create awareness about the issues related to menopause through social media. They are increasing their efficacy in complementary and alternative medicine (CAM) for management of hot flashes.

Get a glimpse of the in-depth analysis through our Report Brochure

Innovations in Devices Attract Healthcare Companies

Apart from innovations in medicines, companies in the menopausal hot flashes treatment market are recommending women toward lifestyle modifications through online media channels. Likewise, companies are developing cutting-edge devices that suit the needs of women. For instance, the introduction of the Menopod™ has led to the growth of market for menopausal hot flashes, owing to its compact computer mouse-like shape and portability. The advent of smartwatch-like devices that act as a personal thermostat for women is also driving the global market.

Due to high prevalence of tech-savvy women in their late 40s, companies in the market for menopausal hot flashes are unearthing value opportunities with the development of mobile apps. These mobile apps are providing healthcare companies with important insights about the frequency of hot flashes in women. On the other hand, companies in the menopausal hot flashes treatment market are increasing research in customizable mattresses that offer cooling and heating temperature controls.

Cognitive Behavior Therapy Proves Effective in Addressing Complications Associated with Hot Flashes

The demand for nonpharmacologic treatment options is projected to escalate in the menopausal hot flashes treatment market. Thus, healthcare providers are adopting cognitive behavior therapy to improve menopause symptoms. This novel therapy is being highly publicized for not only treating hot flashes, but is also effective for other menopause symptoms. Companies in the menopausal hot flashes treatment market are creating awareness about cognitive behavior therapy, owing to its advantages of modifying dysfunctional emotions, behaviors and thoughts that enhance personal coping strategies. Since researchers have gained clinical success with the help of cognitive behavior therapy for the treatment of anxiety and depression, healthcare companies are expanding their healthcare services using the novel therapy.

Complications associated with menopausal hot flashes such as sleep disturbances and low-productivity levels in professional environments are increasing the demand for cognitive behavior therapy among patients. Long-term effectiveness of cognitive behavior therapy post treatment are creating lucrative opportunities for healthcare providers. Thus, healthcare companies are increasing efforts to conduct large-scale clinical trials in order to analyze its effectiveness in highly symptomatic women.

Expanding operations in future? To get the perfect launch ask for a custom report

Analysts’ Viewpoint

Apart from innovations in medicines, alternative options such as weight-training and lifestyle modifications are proving to be effective for hot flashes. The hormone replacement therapy is highly popular in the menopausal hot flashes treatment market. However, controversies encircling the risk of blood clots, stroke, and some cancers pose a barrier for market growth. Hence, companies should tap opportunities in alternative treatment options such as cognitive behavior therapy, which is not only effective in the management of hot flashes, but also treats other symptoms such as anxiety and sleep disorders. Digitalization of health is another key driver contributing toward market growth, as femtech can target tech-savvy women through social media and innovative mobile apps.

Menopausal Hot Flashes Treatment Market: Overview

  • Menopause is defined as the permanent cessation of menses that may occur in as early as the thirties or as late as the sixties. The treatment and management of menopausal women has been a matter of great apprehension in the last few decades, both in terms of epidemiology and medical scientific research.
  • The most common menopausal symptoms, including vasomotor symptoms (menopausal hot flashes), insomnia, vaginal atrophy, altered cognitive function, dementia, depression, and loss of muscle mass, can affect up to 80% of women during menopause and may be severe in up to 20% of these women
  • Menopausal hot flashes symptoms treatment drugs are used to reduce hot flashes, which is a form of temperature dysfunction that occurs due to changes in gonadal hormones. Menopausal hot flashes symptom treatments are classified into hormonal treatment, non-hormonal treatment, and alternative treatment (including herbal products).
  • Hormonal treatment products are available in different dosage forms such as pill, patch, and gel. The use of hormone replacement therapy (HRT) alleviates menopausal hot flashes symptoms and leads to a major improvement in quality of life for women with menopausal hot flashes symptoms.
  • Growing population of elderly women worldwide coupled with rise in menopausal hot flashes symptoms is a major factor responsible for the growth of global menopausal hot flashes treatment market
  • Increase in awareness about women’s health due to different public as well as private organizations initiatives is also fueling the growth of global menopausal hot flashes treatment market
  • Moreover, development of advanced products with alternative mode of administration and changes in lifestyle associated with early menopause are some of the major factors attributed for the growth of global menopausal hot flashes treatment market

Market Segmentation: Menopausal Hot Flashes Treatment Market

  • Based on treatment type, the global menopausal hot flashes treatment market has been divided into hormonal treatment, non-hormonal treatment, and alternative treatment
  • Hormonal treatment is further classified into estrogen, progesterone, and estrogen - progesterone combination
  • The non-hormonal segment is sub-segmented into antidepressant, gabapentin, pregabalin, and clonidine. Antidepressant is further divided into Paroxetine, Fluoxetine, Vanlafaxine, Desvanlafaxine, and others.
  • The alternative segment is further sub-divided into black cohosh, vitamin E, herbal medicines, and others
  • Based on distribution channel, the global menopausal hot flashes treatment market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies
  • Each of the segments has been analyzed in detail for global menopausal hot flashes treatment market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights
  • The global menopausal hot flashes report provides current and future revenues (US$ Mn) for each these segments for the period from 2017 to 2027, considering 2018 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2019 to 2027 along with menopausal hot flashes market size estimations.

Regional Overview: Menopausal Hot Flashes Treatment Market

  • In terms of region, the global menopausal hot flashes treatment market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been further divided into major countries and sub-regions.
  • The current and future market sizes for menopausal hot flashes treatment market in terms of revenue (US$ Mn) of these regional markets and their major countries have been provided in the report for the period from 2017 to 2027, with their CAGRs for the period from 2019 to 2027
  • The study also offers a list of recommendations, highlights, and useful insights of the global menopausal hot flashes treatment market which will help new companies willing to enter the market and existing companies to increase market shares, and help in the decision-making process

Major Players

  • The global menopausal hot flashes report concludes with the company profiles section that includes key information about the major players in the market
  • Key players analyzed in this global menopausal hot flashes treatment market include -
    • Pfizer Inc.
    • Novartis AG
    • Novo Nordisk A/S
    • Allergan plc
    • Teva Pharmaceutical Industries Ltd.
    • Mylan N.V.
    • Hisamitsu Pharmaceutical Co., Inc.
    • Merck & Co., Inc.
    • GlaxoSmithKline plc
    • TherapeuticsMD, Inc
  • Each of these players has been profiled in the menopausal hot flashes treatment market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments

Menopausal Hot Flashes Treatment Market - Segmentation

TMR’s study on the global menopausal hot flashes treatment market includes information divided into three sections - by treatment type, by distribution channel, and by region. Changing industry trends and other crucial market dynamics associated with these sections of the global menopausal hot flashes treatment market have been discussed in detail.

Treatment Type

  • Hormonal Treatment
    • Estrogen
    • Progesterone
    • Estrogen-Progesterone Combination
  • Non-hormonal Treatment
    • Antidepressant
      • Paroxetine
      • Fluoxetine
      • Venlafaxine
      • Desvenlafaxine
      • Others
    • Gabapentin
    • Pregabalin
    • Clonidine
  • Alternative Treatment
    • Black Cohosh
    • Vitamin E
    • Herbal Medicines
    • Others

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Menopausal Hot Flashes Treatment Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of menopausal hot flashes treatment market?

Menopausal hot flashes treatment market is expected to grow at a CAGR of 6% during 2019 - 2027

What are the key driving factors for the growth of the menopausal hot flashes treatment market?

Menopausal hot flashes treatment market is driven by growing awareness about women's health on the back of public as well as private initiatives

Which region is expected to project the highest market share in the global menopausal hot flashes treatment market?

North America accounted for a major share of the global menopausal hot flashes treatment market

Who are the key players in the global menopausal hot flashes treatment market?

Key players in the menopausal hot flashes market include Pfizer Inc., Allergan plc, Novo Nordisk A/S, Novartis AG, TherapeuticsMD, Inc., GlaxoSmithKline plc, Merck & Co., Inc., and Mylan N.V.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Menopausal Hot Flashes Treatment Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Menopausal Hot Flashes Treatment Market Analysis and Forecasts, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Pipeline Analysis

    5.2. Key Mergers, Acquisitions and Strategic Partnerships

    5.3. Value Chain Analysis

6. Global Menopausal Hot Flashes Treatment Market Analysis and Forecasts, By Product Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast By Product Type, 2017–2027

        6.3.1. Hormonal Treatment

            6.3.1.1. Estrogen

            6.3.1.2. Progesterone

            6.3.1.3. Estrogen-Progesterone Combination

        6.3.2. Non-Hormonal Treatment

            6.3.2.1. Antidepressant

                6.3.2.1.1. Paroxetine

                6.3.2.1.2. Fluoxetine

                6.3.2.1.3. Venlafaxine

                6.3.2.1.4. Desvenlafaxine

                6.3.2.1.5. Others

            6.3.2.2. Gabapentin

            6.3.2.3. Progabalin

            6.3.2.4. Clonidine

        6.3.3. Alternative Treatment

            6.3.3.1. Black Cohosh

            6.3.3.2. Vitamin E

            6.3.3.3. Herbal Medicines

            6.3.3.4. Others

    6.4. Market Attractiveness By Product Type, 2019-2027

7. Global Menopausal Hot Flashes Treatment Market Analysis and Forecasts, By Distribution Channel

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast By Distribution Channel, 2017–2027

        7.3.1. Hospital Pharmacies

        7.3.2. Retail Pharmacies

        7.3.3. Online Pharmacies

    7.4. Market Attractiveness By Distribution Channel, 2019-2027

8. Global Menopausal Hot Flashes Treatment Market Analysis and Forecasts, By Region

    8.1. Key Findings

    8.2. Market Value Forecast By Region

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. Market Attractiveness By Country/Region, 2019-2027

9. North America Menopausal Hot Flashes Treatment Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast By Product Type, 2017–2027

        9.2.1. Hormonal Treatment

            9.2.1.1. Estrogen

            9.2.1.2. Progesterone

            9.2.1.3. Estrogen-Progesterone Combination

        9.2.2. Non-Hormonal Treatment

            9.2.2.1. Antidepressant

                9.2.2.1.1. Paroxetine

                9.2.2.1.2. Fluoxetine

                9.2.2.1.3. Venlafaxine

                9.2.2.1.4. Desvenlafaxine

                9.2.2.1.5. Others

            9.2.2.2. Gabapentin

            9.2.2.3. Progabalin

            9.2.2.4. Clonidine

        9.2.3. Alternative Treatment

            9.2.3.1. Black Cohosh

            9.2.3.2. Vitamin E

            9.2.3.3. Herbal Medicines

            9.2.3.4. Others

    9.3. Market Value Forecast By Distribution Channel, 2017–2027

        9.3.1. Hospital Pharmacies

        9.3.2. Retail Pharmacies

        9.3.3. Online Pharmacies

    9.4. Market Value Forecast By Country, 2017–2027

        9.4.1. U.S.

        9.4.2. Canada

    9.5. Market Attractiveness Analysis, 2019-2027

        9.5.1. By Product Type

        9.5.2. By Distribution Channel

        9.5.3. By Country

10. Europe Menopausal Hot Flashes Treatment Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast By Product Type, 2017–2027

        10.2.1. Hormonal Treatment

            10.2.1.1. Estrogen

            10.2.1.2. Progesterone

            10.2.1.3. Estrogen-Progesterone Combination

        10.2.2. Non-Hormonal Treatment

            10.2.2.1. Antidepressant

                10.2.2.1.1. Paroxetine

                10.2.2.1.2. Fluoxetine

                10.2.2.1.3. Venlafaxine

                10.2.2.1.4. Desvenlafaxine

                10.2.2.1.5. Others

            10.2.2.2. Gabapentin

            10.2.2.3. Progabalin

            10.2.2.4. Clonidine

        10.2.3. Alternative Treatment

            10.2.3.1. Black Cohosh

            10.2.3.2. Vitamin E

            10.2.3.3. Herbal Medicines

            10.2.3.4. Others

    10.3. Market Value Forecast By Distribution Channel, 2017–2027

        10.3.1. Hospital Pharmacies

        10.3.2. Retail Pharmacies

        10.3.3. Online Pharmacies

    10.4. Market Value Forecast By Country, 2017–2027

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Spain

        10.4.5. Italy

        10.4.6. Rest of Europe

    10.5. Market Attractiveness Analysis, 2019-2027 

        10.5.1. By Product Type

        10.5.2. By Distribution Channel

        10.5.3. By Country

11. Asia Pacific Menopausal Hot Flashes Treatment Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast By Product Type, 2017–2027

        11.2.1. Hormonal Treatment

            11.2.1.1. Estrogen

            11.2.1.2. Progesterone

            11.2.1.3. Estrogen-Progesterone Combination

        11.2.2. Non-Hormonal Treatment

            11.2.2.1. Antidepressant

                11.2.2.1.1. Paroxetine

                11.2.2.1.2. Fluoxetine

                11.2.2.1.3. Venlafaxine

                11.2.2.1.4. Desvenlafaxine

                11.2.2.1.5. Others

            11.2.2.2. Gabapentin

            11.2.2.3. Progabalin

            11.2.2.4. Clonidine

        11.2.3. Alternative Treatment

            11.2.3.1. Black Cohosh

            11.2.3.2. Vitamin E

            11.2.3.3. Herbal Medicines

            11.2.3.4. Others

    11.3. Market Value Forecast By Distribution Channel, 2017–2027

        11.3.1. Hospital Pharmacies

        11.3.2. Retail Pharmacies

        11.3.3. Online Pharmacies

    11.4. Market Value Forecast By Country, 2017–2027

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Market Attractiveness Analysis, 2019-2027 

        11.5.1. By Product Type

        11.5.2. By Distribution Channel

        11.5.3. By Country

12. Latin America Menopausal Hot Flashes Treatment Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast By Product Type, 2017–2027

        12.2.1. Hormonal Treatment

            12.2.1.1. Estrogen

            12.2.1.2. Progesterone

            12.2.1.3. Estrogen-Progesterone Combination

        12.2.2. Non-Hormonal Treatment

            12.2.2.1. Antidepressant

                12.2.2.1.1. Paroxetine

                12.2.2.1.2. Fluoxetine

                12.2.2.1.3. Venlafaxine

                12.2.2.1.4. Desvenlafaxine

                12.2.2.1.5. Others

            12.2.2.2. Gabapentin

            12.2.2.3. Progabalin

            12.2.2.4. Clonidine

        12.2.3. Alternative Treatment

            12.2.3.1. Black Cohosh

            12.2.3.2. Vitamin E

            12.2.3.3. Herbal Medicines

            12.2.3.4. Others

    12.3. Market Value Forecast By Distribution Channel, 2017–2027

        12.3.1. Hospital Pharmacies

        12.3.2. Retail Pharmacies

        12.3.3. Online Pharmacies

    12.4. Market Value Forecast by Country, 2017–2027

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Market Attractiveness Analysis, 2019-2027 

        12.5.1. By Product Type

        12.5.2. By Distribution Channel

        12.5.3. By Country

13. Middle East & Africa Menopausal Hot Flashes Treatment Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast By Product Type, 2017–2027

        13.2.1. Hormonal Treatment

            13.2.1.1. Estrogen

            13.2.1.2. Progesterone

            13.2.1.3. Estrogen-Progesterone Combination

        13.2.2. Non-Hormonal Treatment

            13.2.2.1. Antidepressant

                13.2.2.1.1. Paroxetine

                13.2.2.1.2. Fluoxetine

                13.2.2.1.3. Venlafaxine

                13.2.2.1.4. Desvenlafaxine

                13.2.2.1.5. Others

            13.2.2.2. Gabapentin

            13.2.2.3. Progabalin

            13.2.2.4. Clonidine

        13.2.3. Alternative Treatment

            13.2.3.1. Black Cohosh

            13.2.3.2. Vitamin E

            13.2.3.3. Herbal Medicines

            13.2.3.4. Others

    13.3. Market Value Forecast By Distribution Channel, 2017–2027

        13.3.1. Hospital Pharmacies

        13.3.2. Retail Pharmacies

        13.3.3. Online Pharmacies

    13.4. Market Value Forecast By Country, 2017–2027

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5. Market Attractiveness Analysis, 2019-2027 

        13.5.1. By Product Type

        13.5.2. By Distribution Channel

        13.5.3. By Country

14. Competition Landscape

    14.1. Market Player – Competition Matrix (By Tier and Size of companies)

    14.2. Market Share/Position Analysis By Company (2018)

    14.3. Company Profiles

        14.3.1. Pfizer Inc.

            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.1.2. Company Financials

            14.3.1.3. Growth Strategies

            14.3.1.4. SWOT Analysis

        14.3.2. Novartis AG

            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.2.2. Company Financials

            14.3.2.3. Growth Strategies

            14.3.2.4. SWOT Analysis

        14.3.3. Novo Nordisk A/S

            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.3.2. Company Financials

            14.3.3.3. Growth Strategies

            14.3.3.4. SWOT Analysis

        14.3.4. Allergan plc.

            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.4.2. Company Financials

            14.3.4.3. Growth Strategies

            14.3.4.4. SWOT Analysis

        14.3.5. Teva Pharmaceutical Industries Ltd.

            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.5.2. Company Financials

            14.3.5.3. Growth Strategies

            14.3.5.4. SWOT Analysis

        14.3.6. Mylan N.V.

            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.6.2. Company Financials

            14.3.6.3. Growth Strategies

            14.3.6.4. SWOT Analysis

        14.3.7. Hisamitsu Pharmaceutical Co., Inc.

            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.7.2. Company Financials

            14.3.7.3. Growth Strategies

            14.3.7.4. SWOT Analysis

        14.3.8. Merck & Co., Inc.

            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.8.2. Company Financials

            14.3.8.3. Growth Strategies

            14.3.8.4. SWOT Analysis

        14.3.9. GlaxoSmithKline plc.

            14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.9.2. Company Financials

            14.3.9.3. Growth Strategies

            14.3.9.4. SWOT Analysis

        14.3.10. TherapeuticsMD, Inc.

            14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.10.2. Company Financials

            14.3.10.3. Growth Strategies

            14.3.10.4. SWOT Analysis

List of Tables

Table 01: Pipeline Analysis, by Phase III

Table 02: Pipeline Analysis, by Phase II, Phase I, and Preclinical

Table 03: Key Mergers, Acquisitions, and Strategic Partnerships

Table 04: Global Menopausal Hot Flashes Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

Table 05: Global Menopausal Hot Flashes Treatment Market Size (US$ Mn) Forecast, by Treatment Type – Hormonal Treatment, 2017–2027

Table 06: Global Menopausal Hot Flashes Treatment Market Size (US$ Mn) Forecast, by Treatment Type – Non-hormonal Treatment, 2017–2027

Table 07: Global Menopausal Hot Flashes Treatment Market Size (US$ Mn) Forecast, by Non-hormonal Treatment – Antidepressant, 2017–2027

Table 08: Global Menopausal Hot Flashes Treatment Market Size (US$ Mn) Forecast, by Treatment Type – Alternative Treatment, 2017–2027

Table 09: Global Menopausal Hot Flashes Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 10: Global Menopausal Hot Flashes Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 11: North America Menopausal Hot Flashes Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2027 

Table 12: North America Menopausal Hot Flashes Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

Table 13: North America Menopausal Hot Flashes Treatment Market Size (US$ Mn) Forecast, by Treatment Type – Hormonal Treatment, 2017–2027

Table 14: North America Menopausal Hot Flashes Treatment Market Size (US$ Mn) Forecast, by Treatment Type – Non-hormonal Treatment, 2017–2027

Table 15: North America Menopausal Hot Flashes Treatment Market Size (US$ Mn) Forecast, by Non-hormonal Treatment – Antidepressant, 2017–2027

Table 16: North America Menopausal Hot Flashes Treatment Market Size (US$ Mn) Forecast, by Treatment Type – Alternative Treatment, 2017–2027

Table 17: North America Menopausal Hot Flashes Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 18: Europe Menopausal Hot Flashes Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027 

Table 19: Europe Menopausal Hot Flashes Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

Table 20: Europe Menopausal Hot Flashes Treatment Market Value (US$ Mn) Forecast, by Treatment Type – Hormonal Treatment, 2017–2027

Table 21: Europe Menopausal Hot Flashes Treatment Market Value (US$ Mn) Forecast, by Treatment Type – Non-hormonal Treatment, 2017–2027

Table 22: Europe Menopausal Hot Flashes Treatment Market Value (US$ Mn) Forecast, by Non-hormonal Treatment – Antidepressants, 2017–2027

Table 23: Europe Menopausal Hot Flashes Treatment Market Value (US$ Mn) Forecast, by Treatment Type – Alternative Treatment, 2017–2027

Table 24: Europe Menopausal Hot Flashes Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 25: Asia Pacific Menopausal Hot Flashes Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027 

Table 26: Asia Pacific Menopausal Hot Flashes Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

Table 27: Asia Pacific Menopausal Hot Flashes Treatment Market Size (US$ Mn) Forecast, by Treatment Type – Hormonal Treatment, 2017–2027

Table 28: Asia Pacific Menopausal Hot Flashes Treatment Market Size (US$ Mn) Forecast, by Treatment Type – Non-hormonal Treatment, 2017–2027

Table 29: Asia Pacific Menopausal Hot Flashes Treatment Market Size (US$ Mn) Forecast, by Non-hormonal Treatment – Antidepressant, 2017–2027

Table 30: Asia Pacific Menopausal Hot Flashes Treatment Market Size (US$ Mn) Forecast, by Treatment Type – Alternative Treatment, 2017–2027

Table 31: Asia Pacific Menopausal Hot Flashes Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 32: Latin America Menopausal Hot Flashes Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027 

Table 33: Latin America Menopausal Hot Flashes Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

Table 34: Latin America Menopausal Hot Flashes Treatment Market Size (US$ Mn) Forecast, by Treatment Type – Hormonal Treatment, 2017–2027

Table 35: Latin America Menopausal Hot Flashes Treatment Market Size (US$ Mn) Forecast, by Treatment Type – Non-hormonal Treatment, 2017–2027

Table 36: Latin America Menopausal Hot Flashes Treatment Market Size (US$ Mn) Forecast, by Non-hormonal Treatment – Antidepressant, 2017–2027

Table 37: Latin America Menopausal Hot Flashes Treatment Market Size (US$ Mn) Forecast, by Treatment Type – Alternative Treatment, 2017–2027

Table 38: Latin America Menopausal Hot Flashes Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 39: Middle East & Africa Menopausal Hot Flashes Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027 

Table 40: Middle East & Africa Menopausal Hot Flashes Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

Table 41: Middle East & Africa Menopausal Hot Flashes Treatment Market Size (US$ Mn) Forecast, by Treatment Type – Hormonal Treatment, 2017–2027

Table 42: Middle East & Africa Menopausal Hot Flashes Treatment Market Size (US$ Mn) Forecast, by Treatment Type – Non-hormonal Treatment, 2017–2027

Table 43: Middle East & Africa Menopausal Hot Flashes Treatment Market Size (US$ Mn) Forecast, by Non-hormonal Treatment – Antidepressant, 2017–2027

Table 44: Middle East & Africa Menopausal Hot Flashes Treatment Market Size (US$ Mn) Forecast, by Treatment Type – Alternative Treatment, 2017–2027

Table 45: Middle East & Africa Menopausal Hot Flashes Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

List of Figures

Figure 01: Global Menopausal Hot Flashes Treatment Market Size (US$ Mn) and Distribution, by Region, 2018 and 2027

Figure 02: Global Menopausal Hot Flashes Treatment Market Value (US$ Mn) Analysis, 2017–2027

Figure 03: Global Menopausal Hot Flashes Treatment Market Value Share, by Treatment Type (2018)

Figure 04: Global Menopausal Hot Flashes Treatment Market Value Share, by Distribution Channel (2018)

Figure 05: Global Menopausal Hot Flashes Treatment Market Value Share, by Region (2018)

Figure 06: Global Menopausal Hot Flashes Treatment Market Value Share, by Non-hormonal Treatment (2018)

Figure 07: Global Menopausal Hot Flashes Treatment Market Value Share, by Hormonal Treatment (2018)

Figure 08: Global Menopausal Hot Flashes Treatment Market Value Share, by Alternative Treatment (2018)

Figure 09: Global Menopausal Hot Flashes Treatment Market Value Share, by Antidepressant (2018)

Figure 10: Global Menopausal Hot Flashes Treatment Market Value Share Analysis, by Treatment Type, 2018 and 2027

Figure 11: Global Menopausal Hot Flashes Treatment Market Value Share, by Hormonal Treatment, 2018 and 2027

Figure 12: Global Menopausal Hot Flashes Treatment Market Value Share, by Non-hormonal Treatment, 2018 and 2027

Figure 13: Global Menopausal Hot Flashes Treatment Market Value Share, by Alternative Treatment, 2018 and 2027

Figure 14: Global Menopausal Hot Flashes Treatment Market Value Share, by Antidepressant, 2018 and 2027

Figure 15: Global Menopausal Hot Flashes Treatment Market Revenue (US$ Mn) and Y-o-Y (%) Analysis, by Hormonal Treatment, 2017–2027

Figure 16: Global Menopausal Hot Flashes Treatment Market Revenue (US$ Mn) and Y-o-Y (%) Analysis, by Non-hormonal Treatment, 2017–2027

Figure 17: Global Menopausal Hot Flashes Treatment Market Revenue (US$ Mn) and Y-o-Y (%) Analysis, by Alternative Treatment, 2017–2027

Figure 18: Global Menopausal Hot Flashes Treatment Market Attractiveness Analysis, by Treatment Type, 2019–2027

Figure 19: Global Menopausal Hot Flashes Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 20: Global Menopausal Hot Flashes Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2017–2027

Figure 21: Global Menopausal Hot Flashes Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2017–2027

Figure 22: Global Menopausal Hot Flashes Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2017–2027

Figure 23: Global Menopausal Hot Flashes Treatment Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 24: Global Menopausal Hot Flashes Treatment Market Value Share Analysis, by Region, 2018 and 2027

Figure 25: Global Menopausal Hot Flashes Treatment Market Attractiveness Analysis, by Region, 2019–2027

Figure 26: North America Menopausal Hot Flashes Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 27: North America Menopausal Hot Flashes Treatment Market Value Share, by Country, 2018 and 2027

Figure 28: North America Menopausal Hot Flashes Treatment Market Attractiveness, by Country, 2019–2027

Figure 29: North America Menopausal Hot Flashes Treatment Market Value Share, by Treatment Type, 2018 and 2027

Figure 30: North America Menopausal Hot Flashes Treatment Market Attractiveness, by Treatment Type, 2019–2027

Figure 31: North America Menopausal Hot Flashes Treatment Market Value Share, by Hormonal Treatment, 2018 and 2027

Figure 32: North America Menopausal Hot Flashes Treatment Market Value Share, by Non-hormonal Treatment, 2018 and 2027

Figure 33: North America Menopausal Hot Flashes Treatment Market Value Share, by Alternative Treatment, 2018 and 2027

Figure 34: North America Menopausal Hot Flashes Treatment Market Value Share, by Antidepressant, 2018 and 2027

Figure 35: North America Menopausal Hot Flashes Treatment Market Value Share, by Distribution Channel, 2018 and 2027

Figure 36: North America Menopausal Hot Flashes Treatment Market Attractiveness, by Distribution Channel, 2019–2027

Figure 37: Europe Menopausal Hot Flashes Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017–2027

Figure 38: Europe Menopausal Hot Flashes Treatment Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 39: Europe Menopausal Hot Flashes Treatment Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 40: Europe Menopausal Hot Flashes Treatment Market Value Share, by Treatment Type, 2018 and 2027

Figure 41: Europe Menopausal Hot Flashes Treatment Market Attractiveness, by Treatment Type, 2019–2027

Figure 42: Europe Menopause Menopausal Hot Flashes Treatment Market Value Share, by Hormonal Treatment, 2018 and 2027

Figure 43: Europe Menopausal Hot Flashes Treatment Market Value Share, by Non-hormonal Treatment, 2018 and 2027

Figure 44: Europe Menopausal Hot Flashes Treatment Market Value Share, by Alternative Treatment, 2018 and 2027

Figure 45: Europe Menopausal Hot Flashes Treatment Market Value Share, by Antidepressant, 2018 and 2027

Figure 46: Europe Menopausal Hot Flashes Treatment Market Value Share, by Distribution Channel, 2018 and 2027

Figure 47: Europe Menopausal Hot Flashes Treatment Market Attractiveness, by Distribution Channel, 2019–2027

Figure 48: Asia Pacific Menopausal Hot Flashes Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 49: Asia Pacific Menopausal Hot Flashes Treatment Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 50: Asia Pacific Menopausal Hot Flashes Treatment Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 51: Asia Pacific Menopausal Hot Flashes Treatment Market Value Share, by Treatment Type, 2018 and 2027

Figure 52: Asia Pacific Menopausal Hot Flashes Treatment Market Attractiveness, by Treatment Type, 2019–2027

Figure 53: Asia Pacific Menopausal Hot Flashes Treatment Market Value Share, by Hormonal Treatment, 2018 and 2027

Figure 54: Asia Pacific Menopausal Hot Flashes Treatment Market Value Share, by Non-hormonal Treatment, 2018 and 2027

Figure 55: Asia Pacific Menopausal Hot Flashes Treatment Market Value Share, by Alternative Treatment, 2018 and 2027

Figure 56: Asia Pacific Menopausal Hot Flashes Treatment Market Value Share, by Antidepressant, 2018 and 2027

Figure 57: Asia Pacific Menopausal Hot Flashes Treatment Market Value Share, by Distribution Channel, 2018 and 2027

Figure 58: Asia Pacific Menopausal Hot Flashes Treatment Market Attractiveness, by Distribution Channel, 2019–2027

Figure 59: Latin America Menopausal Hot Flashes Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 60: Latin America Menopausal Hot Flashes Treatment Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 61: Latin America Menopausal Hot Flashes Treatment Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 62: Latin America Menopausal Hot Flashes Treatment Market Value Share, by Treatment Type, 2018 and 2027

Figure 63: Latin America Menopausal Hot Flashes Treatment Market Attractiveness, by Treatment Type, 2019–2027

Figure 64: Latin America Menopausal Hot Flashes Treatment Market Value Share, by Hormonal Treatment, 2018 and 2027

Figure 65: Latin America Menopausal Hot Flashes Treatment Market Value Share, by Non-hormonal Treatment, 2018 and 2027

Figure 66: Latin America Menopausal Hot Flashes Treatment Market Value Share, by Alternative Treatment, 2018 and 2027

Figure 67: Latin America Menopausal Hot Flashes Treatment Market Value Share, by Antidepressant, 2018 and 2027

Figure 68: Latin America Menopausal Hot Flashes Treatment Market Value Share, by Distribution Channel, 2018 and 2027

Figure 69: Latin America Menopausal Hot Flashes Treatment Market Attractiveness, by Distribution Channel, 2019–2027

Figure 70: Middle East & Africa Menopausal Hot Flashes Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 71: Middle East & Africa Menopausal Hot Flashes Treatment Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 72: Middle East & Africa Menopausal Hot Flashes Treatment Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 73: Middle East & Africa Menopausal Hot Flashes Treatment Market Value Share, by Treatment Type, 2018 and 2027

Figure 74: Middle East & Africa Menopausal Hot Flashes Treatment Market Attractiveness, by Treatment Type, 2019–2027

Figure 75: Middle East & Africa Menopausal Hot Flashes Treatment Market Value Share, by Hormonal Treatment, 2018 and 2027

Figure 76: Middle East & Africa Menopausal Hot Flashes Treatment Market Value Share, by Non-hormonal Treatment, 2018 and 2027

Figure 77: Middle East & Africa Menopausal Hot Flashes Treatment Market Value Share, by Alternative Treatment, 2018 and 2027

Figure 78: Middle East & Africa Menopausal Hot Flashes Treatment Market Value Share, by Antidepressant, 2018 and 2027

Figure 79: Middle East & Africa Menopausal Hot Flashes Treatment Market Value Share, by Distribution Channel, 2018 and 2027

Figure 80: Middle East & Africa Menopausal Hot Flashes Treatment Market Attractiveness, by Distribution Channel, 2019–2027

Figure 81: Market Position Analysis, 2018, by Tier and Size of the Company

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

332

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved